Skip to main content

Table 2 Univariate and multivariate analysis for survival in the training cohort

From: A prognostic nomogram to predict survival in elderly patients with small-cell lung cancer: a large population-based cohort study and external validation

Variables

Overall survival

Cancer-specific survival

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

log rank X2

P value

HR(95% CI)

P value

log rank X2

P value

HR(95% CI)

P value

Sex

7.573

0.006

  

5.096

0.024

  

 Female

  

Reference

  

Reference

 Male

  

1.122(1.0160–1.239)

0.023

  

1.115(1.009–1.232)

0.033

Age (year)

60.828

< 0.001

 

< 0.001

57.346

< 0.001

 

< 0.001

 60–69

  

Reference

  

Reference

 70–79

  

1.125(1.014–1.249)

0.027

  

1.105(0.991–1.232)

0.072

  ≥ 80

  

1.403(1.215–1.621)

< 0.001

  

1.422(1.225–1.651)

< 0.001

Race

3.169

0.205

  

2.239

0.326

  

 Black

        

 White

        

 Others

        

Marital status

3.877

0.049

  

3.243

0.072

  

 Married

  

Reference

   

 Unmarried/single

  

0.943(0.852–1.044)

0.260

    

Insurance

7.334

0.026

 

0.139

6.300

0.043

 

0.201

 Insured

  

Reference

  

Reference

 Any medicaid

  

1.156(0.998–1.339)

0.053

  

1.136(0.977–1.322)

0.098

 Uninsured

  

1.114(0.776–1.600)

0.558

  

1.158(0.802–1.673)

0.435

Location

13.801

0.008

 

0.890

13.333

0.010

 

0.912

 main bronchus

  

Reference

  

Reference

 upper lobe, lung

  

0.981(0.834–1.155)

0.821

  

0.989(0.835–1.172)

0.900

 middle lobe, lung

  

0.938(0.723–1.216)

0.627

  

0.909(0.691–1.195)

0.493

 low lobe, lung

  

1.029(0.862–1.228)

0.753

  

1.021(0.849–1.227)

0.829

 overlapping lesion

  

0.942(0.650–1.365)

0.752

  

0.968(0.661–1.418)

0.869

Grade

8.509

0.014

 

0.103

6.444

0.040

 

0.207

 I

  

Reference

  

Reference

 II

  

1.217(0.935–1.584)

0.072

  

1.420(0.871–2.313)

0.160

 III/IV

  

1.672(1.276–2.191)

0.046

  

1.487(0.915–2.417)

0.109

AJCC TNM stage(7th)

325.842

< 0.001

 

< 0.001

333.677

< 0.001

 

< 0.001

 I

  

Reference

  

Reference

 II

  

1.057(0.759–1.472)

0.743

  

1.196(0.835–1.714)

0.328

 III

  

2.020(1.583–2.579)

< 0.001

  

2.257(1.723–2.957)

< 0.001

 IV

  

2.456(1.904–3.167)

< 0.001

  

2.816(2.128–3.726)

< 0.001

Surgery

94.156

< 0.001

  

93.865

< 0.001

  

 No

  

Reference

  

Reference

 Yes

  

0.455(0.356–0.580)

< 0.001

  

0.449(0.345–0.585)

< 0.001

Chemotherapy

399.497

< 0.001

  

357.865

< 0.001

  

 No/unknown

  

Reference

  

Reference

 Yes

  

0.358(0.318–0.403)

< 0.001

  

0.355(0.314–0.401)

< 0.001

Radiaton

228.240

< 0.001

  

200.382

< 0.001

  

 No/unknown

  

Reference

  

Reference

 Yes

  

0.646(0.578–0.723)

< 0.001

  

0.663(0.590–0.746)

< 0.001

Bone metastasis

108.425

< 0.001

  

117.648

< 0.001

  

 No

  

Reference

  

Reference

 Yes

  

1.145(1.008–1.301)

0.037

  

1.168(1.025–1.332)

0.020

Brain metastasis

37.292

< 0.001

  

38.774

< 0.001

  

 No

  

Reference

  

Reference

 Yes

  

1.339(1.159–1.547)

< 0.001

  

1.345(1.158–1.562)

< 0.001

Liver metastasis

237.796

< 0.001

  

244.918

< 0.001

 

 No

  

Reference

  

Reference

 Yes

  

1.490(1.316–1.689)

< 0.001

  

1.531(1.346–1.742)

< 0.001

Lung metastasis

52.925

< 0.001

  

54.613

< 0.001

  

 No

  

Reference

  

Reference

 Yes

  

1.128(0.979–1.300)

0.096

  

1.132(0.978–1.311)

0.097

size

78.492

< 0.001

 

< 0.001

85.026

< 0.001

 

< 0.001

  ≤ 3 cm

  

Reference

  

Reference

 3.1-5 cm

  

1.249(1.097–1.422)

0.001

  

1.285(1.121–1.473)

< 0.001

 5.1-7 cm

  

1.297(1.121–1.501)

< 0.001

  

1.309(1.123–1.526)

0.001

 >7 cm

  

1.365(1.185–1.572)

< 0.001

  

1.410(1.217–1.634)

< 0.001

  1. AJCC American Joint Committee for Cancer, TNM Tumor-Node-Metastasis